Scandal with the Law costing medicines between $7 and $45,000, Minister Arben Vitita annuls the decision

The bar under the name “Iruzed” of 7 euros in retail sales, with the Official List of Prices of Medical Products sold to over 48 thousand.

For example, the 5mg Dopezal product (used for people who have a problem with forgetting) currently costs 6,80 euros, with the new drug law cost 9.72 euros, or 2.92 euros more expensive, or the antibiotic called Envexia, which currently costs 7 euros with the Law on Drugs, will cost 15.85 euros, or 8.85 euros more than the current price.

The Fiscal bar that you used against the womb, currently in the market, costs 2.40 euros, while with the Law on the Price of Drugs, it will cost 2.97, Pytenra another product that you currently used for blood transmission costs 25 euros, while at the new price it will cost 30.33 euros or 5.33 euros more expensive. Travazoli, the product currently used for skin, cost 3.80 euros at the new price, will cost 11.27 euros or 7.47 euros more expensive, another pharmaceutical product like LisinoConp, currently cost 6.70 euros at the new price, will cost 8.78 euros.

The new seven-page law, for the appointment of the price of medical products, due to these price scandals, has been cancelled on June 7th, 2024 at the decision of Minister of Health Arben Vitita.

Here you see the difference in the current price of some pharmaceutical products and the price they will have with the new Law.

Meanwhile, the chairman of the Bars Award Commission, Virtue Krasniqi, has said that for our questions she has provided answers to the Ministry of Health.

” For your questions, I gave answers to the Ministry of Health and from them you can get” Krasniqi said February for FrontOnline.

Tolaj: Price Commission Takes to Determine, Not AKPM

The head of the Kosovo Agency for Products and Medicines Syed Tolaj tells FrontOnline that the issue of the price of medicines is not in their hands, demanding that questions be sent to the Ministry of Health and to the Commission for the Price of Drugs.

If the organ doesn't respond, price troops, what am I supposed to do? )

Tolaj, says they do not control prices and that the prices of drugs are not sent to them.

The price commission deals with price setting. We don't control prices, we don't deliver prices to us companies.

Tolaj, says it's not about them and that they don't want to get involved in other things.

When it's not about us, it's about getting involved in someone else's powers it's not good” ends up short Tolaj.

OFK Vice Chairman: Strong support for the Law on Barnates, Commission on the Law of Prices and Disfellowshipping

The deputy chairman of the Kosovo Pharmacists' House (OFK), Astrit Hadzijaha, says they are in the final phase of the complaints and that he believes that within a week or two, the implementation of the New Law on Barna will begin.

We're in the complaint phase and I think within a week or two we can follow the law. Looking at details and paragraphs and a new law for the first time, I think it's okay except for some technical issues that are pending, he declares.

Hadziha, says he has also seen that certain medical products will have price increases and that there are other products that will be applied.

Yeah, it's true, I've seen the signs, or the decision to approve the essential list. There have been 2300 drugs that have applied and expected 800-1000 that will be applied so we can continue treatment. So in these 2300s I've seen that there's a change of prices and increases of them, like Aspirin at the moment there's 2 euros in the new law, and then there's other products, but it's no excuse if there's 2050 price hikes and we don't get you technicalally.

The double of the OFK says their oda strongly supports the implementation of this law.

) The OFK strongly supports the implementation of this law.

Likewise, Hadzijaha says that their envoy to the Commission for the Barnat Award Law has been ruled out for no reason whatsoever.

I think it's the Commission for the Price Law that treats them and the envoy from the OFK has been excluded, and another commission has been revised again, in which we as ours have been informed that the member you've delegated has been expelled, he declares.

The deputy head of the Kosovo Pharmacists' House has also spoken of products that are not accepted by the Ministry of Health.

No. This goes into stock procedure, when new stocks come in, they have to be treated at the price approved. One of the criteria has been the monitoring list of the Kosovo distribution plant, and they have not forwarded the factories in real time, and for that they have remained out of the other province, but there will be another deadline to deal with them as well.

Haxhiu for the Barna Award Law: It is paper thief for pharmaceutical oligarchs and to the harm of patients and citizens

MP PDK, Bekim Haxhiu, once a member of the Commission for Health, says there would have to be a reduction of the price of medicines with the new law, not its growth.

Cleaning up medical products would have to have a discount. Through the Drug Price Tax Commission, the MSH has made an increase in the price of drugs, this increase is higher than the retail price in drugs, he points out.

Haxhiu, for example, considers changing the price of drugs with the new law, as long as he considers it to be the propaganda tendency of the VV to say in public that this law regulates the field of drugs, but after the price publication, this is turning out to be a fraud, and it only suits pharmacists' mafia and citizen harm.

For example, Aspirin at the drug store costs 1.8 euros to 2 euros, will cost the new law 2.85 euros. By law, MV, Kurt and VV have wanted to sell as propaganda that they are willing to regulate this sphere, but after the price publication, we see that there are only increases of them and winners are the pharmaceutical mafia and pharmaceutical oligarchs that are directly linked to the MSH, that goes to the harm of Kosovo citizens and patients.

MP Haxhiu considers the fraud and theft of patients and citizens the law on drugs, until he points to their idea ( PDK's for fixing the price of drugs.

This is also a fraud and a patient's theft. The goal has been to buy a medical product at the same price across Kosovo, and they are not affected at high prices and there is no change of prices, so our goal with former Prime Minister Ismaili has been to have a drug price unification, but to have a price unification, but not a higher one.

Finally, Haxhi calls it the law on medicine.

This is paper thief in favor of oligarchs and at the expense of patients.

Dress: There are doubts about the price of drugs, that's why we invited debate on Monday.

Shemsedin Dresey, AAK deputy, once a member of the Commission for Health and Social Goodness, says about FrontOnline, that the New Law on Barnat has been approved, has been debated, but has not yet entered into force.

This law has been passed, this law has been debated and harmonised, but it has not yet entered into force.

Dress, says the very day Monday has called for debate on this law and has invited the Oda of Doctors and the Association of Pharmacists to ask them how much this law is being respected and implemented.

The Parliamentary Group for Health has applied for a debate in the coming week, namely on Monday to have a debate over the Oda of Doctors, the Association of Pharmacheut, about how respected and this law is being implemented.

The AAK MP says he has doubts about the price of drugs.

Because of these allegations we have invited the MSH and Oda of the Pharmacists to discuss this matter.

Slumd: 2,200 pharmaceutical products not accepted by MSH are circulating in Kosovo

The chairman of Kosovo's Pharmaceutical Distribution Association, Ismajl Shudhaj, has spoken legally with the Barnat Award Law.

Shurdaj says there are also 2,000 and 200 products, or about 40% of other products, have not yet been accepted by the Ministry of Health, since, according to him, the legal deadline for statements has passed.

There are also 2,200 products, or better said, about 40% of the other products that circulate on the Kosovo market and which have not yet been accepted by the MSH, because according to them the pre-proliferation legal deadline has passed by one day, so that about 40% of the products are undeclared; prices are undeclared; he emphasises.

The head of the USDF, says health insurance would be the basis for fixing the price of medicines.

I have not, in effect, seen so far that Kosovo has not adjusted the health regulation issue, because health insurance would have been basic, foundation, regulation of pharmaceutical prices and health services, so far we lack the Fund for Health Insurance and, in its absence, so far, the pharmaceutical market in Kosovo has been free as any other market has been declared.

Shudhaj says that with the new law, the pharmaceuticals are expected to earn about 25%, which is considered to be the real value of winning.

Since we're in this situation, we have drugs that don't earn how much they can earn with this law, 25%, they probably earn less, they earn 15%, 20% 10% in some products here is the difference, because they've got a 25% meds that I think is real, while there are drugs in Kosovo that earn 10%, 15% and so that's what he's doing.

The chairman of Kosovo's pharmaceutical distribution association says that many distributors have feared what would happen after this law and how the price procedure will go.

On the other hand, we may also have a raise because it's the first time we've declared prices, because even many pharmaceutical distributors have been afraid of how the price procedure is going, and maybe they've raised prices more than they should, because we know that if a pharmaceutical firm has 10 or 5 products, five of these can get out of the market, and that's what they're afraid of.

Even this law will not solve problems and discontent until it says they are to regulate these issues.

We know there's problems, there's problems, and we can't fix them the first time. We protect our members, we've always been skeptical in this law, we've been for the neevilation of prices to regulate this issue within the reach of our current laws and how much our Constitution protects us. Health insurance is missing, we've been skeptical that this issue is being fixed. We have places where we can get the experience of other countries, how they started this process, not where they are today, but where they are.

Shurdaj, says that Slovenia and Greece have taken Slovenia as a model for Kosovo pharmaceutical development, because it is more appropriate and applicable.

As a model, we have Slovenia and Greece, and Croatia because pharmacists there themselves have said it has not been a good model for pharmaceutical development. You know, we're a small market and we need molecules and drugs registered in this market, and by this law, if they go out at inappropriate prices, they risk a lot of them being attracted, and the damage would be much bigger than we think it would be.

The head of the SHDFK, states that with a seven-page law, not all issues can be settled, but care should be taken care of.

We've written an S.H.I.D. because there's been complaints by our members, luckily I don't know how it's gonna be. It's a lack of law, a 7-page law, and such a law cannot regulate this case. It should be very careful how we conduct ourselves in this case.